Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Danaher (DHR) Stock Forecast & Price Target

Danaher logo
$206.09 +0.80 (+0.39%)
Closing price 03:59 PM Eastern
Extended Trading
$206.36 +0.27 (+0.13%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Danaher - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 20 Analyst Ratings
Sell
0
Hold
3
Buy
17

Based on 20 Wall Street analysts who have issued ratings for Danaher in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 3 have given a hold rating, and 17 have given a buy rating for DHR.

Consensus Price Target

$247.61
20.15% Upside
According to the 20 analysts' twelve-month price targets for Danaher, the average price target is $247.61. The highest price target for DHR is $315.00, while the lowest price target for DHR is $205.00. The average price target represents a forecasted upside of 20.15% from the current price of $206.09.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for DHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Danaher and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DHR Analyst Ratings Over Time

TypeCurrent Forecast
8/29/24 to 8/29/25		1 Month Ago
7/30/24 to 7/30/25		3 Months Ago
5/31/24 to 5/31/25		1 Year Ago
8/30/23 to 8/29/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
17 Buy rating(s)
17 Buy rating(s)
16 Buy rating(s)
11 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$247.61$247.61$248.77$278.94
Forecasted Upside20.15% Upside21.23% Upside31.25% Upside4.41% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

DHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Danaher Stock vs. The Competition

TypeDanaherMedical CompaniesS&P 500
Consensus Rating Score
2.85
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside20.15% Upside15,813.39% Upside10.23% Upside
News Sentiment Rating
Very Positive News

See Recent DHR News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/23/2025UBS Group
3 of 5 stars		Dan Leonard
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$240.00 ➝ $225.00+13.61%
7/23/2025Wells Fargo & Company
3 of 5 stars		Brandon Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetEqual Weight ➝ Equal Weight$210.00 ➝ $205.00+4.31%
7/23/2025Guggenheim
2 of 5 stars		Subbu Nambi
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingBuy ➝ Buy$250.00+31.55%
7/18/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Catherine Schulte
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetOutperform ➝ Outperform$225.00 ➝ $226.00+16.01%
7/11/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Sung Ji Nam
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeSector Perform ➝ Sector Outperform$275.00+33.79%
7/8/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Vijay Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform ➝ Outperform$230.00 ➝ $226.00+13.23%
6/24/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		L. Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$215.00 ➝ $225.00+14.20%
6/5/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$240.00 ➝ $235.00+22.45%
4/25/2025HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$270.00 ➝ $240.00+21.41%
4/23/2025Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform$225.00 ➝ $230.00+17.04%
4/23/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$240.00 ➝ $248.00+26.20%
4/23/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$260.00 ➝ $240.00+22.13%
4/23/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Conor McNamara
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform ➝ Outperform$250.00 ➝ $250.00+25.71%
4/23/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Sykes
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetNeutral ➝ Neutral$260.00 ➝ $240.00+20.47%
4/22/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Tycho Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetBuy ➝ Buy$260.00 ➝ $230.00+19.75%
4/22/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Tycho Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOverweight ➝ Overweight$280.00 ➝ $260.00+35.37%
4/14/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$265.00 ➝ $230.00+19.16%
4/7/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy
4/7/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform$275.00 ➝ $220.00+21.74%
3/14/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Daniel Arias
Subscribe to MarketBeat All Access for the recommendation accuracy rating		UpgradeHold ➝ Buy$260.00+27.48%
2/3/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Andrew Cooper
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOutperform ➝ Market Perform
10/23/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Johnson
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingOverweight ➝ Overweight$315.00 ➝ $315.00+23.29%
10/23/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$290.00 ➝ $310.00+19.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:37 PM ET.


Should I Buy Danaher Stock? DHR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 27, 2025. Please send any questions or comments about these Danaher pros and cons to contact@marketbeat.com.

Danaher
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Danaher Co.:

  • Danaher Co. has received multiple upgrades from analysts, with a consensus rating of "Moderate Buy" and a target price around $247.61, indicating strong potential for price appreciation.
  • The current stock price is approximately $206, which is significantly lower than its 52-week high of $279.90, suggesting a potential buying opportunity for investors looking for value.
  • Recent earnings reports show that Danaher Co. exceeded expectations with earnings per share of $1.80, reflecting a solid performance and a year-over-year revenue increase of 3.4%.
  • Seventeen analysts have rated the stock with a Buy rating, demonstrating strong confidence in the company's future performance and stability.
  • Danaher Co. has a relatively low debt-to-equity ratio of 0.32, indicating a strong balance sheet and lower financial risk, which is attractive for long-term investors.

Danaher
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Danaher Co. for these reasons:

  • The stock has a high price-to-earnings (P/E) ratio of around 45.04, which may suggest that it is overvalued compared to its earnings, potentially limiting future price growth.
  • Despite recent upgrades, some analysts have lowered their price targets, indicating a lack of consensus on the stock's near-term performance.
  • Danaher Co. operates in a competitive market, and any significant changes in industry dynamics could adversely affect its market position and profitability.
  • Insider ownership is at 11.20%, which, while not low, may indicate limited alignment between management and shareholder interests, potentially affecting decision-making.
  • The stock has shown volatility, with a beta of 0.73, suggesting that it may not be as stable as some investors prefer, especially in uncertain market conditions.

DHR Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Danaher is $247.61, with a high forecast of $315.00 and a low forecast of $205.00.

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 3 hold ratings and 17 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DHR shares.

According to analysts, Danaher's stock has a predicted upside of 20.15% based on their 12-month stock forecasts.

Over the previous 90 days, Danaher's stock had 1 upgrade by analysts.

Danaher has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Evercore ISI, Guggenheim, Robert W. Baird, Scotiabank, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Danaher more than other "medical" companies. The consensus rating score for Danaher is 2.85 while the average consensus rating score for "medical" companies is 2.78. Learn more on how DHR compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NYSE:DHR) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel